NCT03098810 is a Phase 4 clinical trial of Zinc sulphate in Appetite Disorders, sponsored by Ain Shams University.

Who is sponsoring NCT03098810?

NCT03098810 is sponsored by Ain Shams University.

What drugs are being tested in NCT03098810?

Interventions in NCT03098810: Zinc sulphate, Placebo.

What condition does NCT03098810 study?

NCT03098810 studies Appetite Disorders.

Is NCT03098810 still recruiting?

NCT03098810 is currently status unknown. Last updated 4 April 2017.

Last reviewed 2017-04-04 · How we verify

NCT03098810

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Zinc Supplementation on Appetite and Growth in Primary Malnourished Children

Status unknown Phase 4 Last updated 4 April 2017

What this trial tests

Phase 4 trial testing Zinc sulphate in Appetite Disorders in 50 participants. Status unknown.

Timeline

1 April 2017

Primary endpoint
1 September 2017

1 December 2017

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 April 2017
Primary completion	1 September 2017
Estimated completion	1 December 2017

Drugs / interventions tested

Zinc sulphate
Placebo

Conditions studied

Appetite Disorders — all drugs for Appetite Disorders →

Sponsor

Ain Shams University

Who can join

Adults 2 to 10, any sex, with Appetite Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Zinc supplementation effect on appetite and growth of malnourished children

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years.
Imdad A, Rogner J, Sherwani RN, Sidhu J, et al · · 2023 · cited 26× · PMID 36994923 · DOI 10.1002/14651858.cd009384.pub3

Verify or expand the search:

Other recruiting trials for Appetite Disorders

Currently open trials in the same condition.

NCT07153549 — Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502) · NA · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03098810 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 4 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03098810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing